Nuveen Asset Management, LLC Jazz Pharmaceuticals PLC Transaction History

Nuveen Asset Management, LLC

$334 Billion
Q2 2024

A detailed history of Nuveen Asset Management, LLC transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 417,991 shares of JAZZ stock, worth $46.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

417,991

Previous 443,531 5.76%

Holding current value

$46.4 Million

Previous $53.4 Million 16.47%

% of portfolio

0.01%

Previous 0.02%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$103.94 - $118.98 $2.65 Million - $3.04 Million	-25,540 Reduced 5.76%	417,991 $44.6 Million
Q1 2024 May 13, 2024	BUY	$115.19 - $132.77 $19.4 Million - $22.4 Million	168,618 Added 61.34%	443,531 $53.4 Million
Q4 2023 Feb 14, 2024	BUY	$114.26 - $136.0 $4.34 Million - $5.17 Million	38,023 Added 16.05%	274,913 $33.8 Million
Q3 2023 Nov 14, 2023	SELL	$122.0 - $145.31 $12.7 Million - $15.2 Million	-104,393 Reduced 30.59%	236,890 $30.7 Million
Q2 2023 Aug 14, 2023	SELL	$122.5 - $147.16 $17.5 Million - $21.1 Million	-143,142 Reduced 29.55%	341,283 $42.3 Million
Q1 2023 May 15, 2023	BUY	$133.98 - $160.47 $1.13 Million - $1.36 Million	8,452 Added 1.78%	484,425 $70.9 Million
Q4 2022 Feb 14, 2023	BUY	$129.72 - $159.85 $7.37 Million - $9.08 Million	56,810 Added 13.55%	475,973 $75.8 Million
Q3 2022 Nov 14, 2022	SELL	$126.59 - $161.18 $495,726 - $631,180	-3,916 Reduced 0.93%	419,163 $55.9 Million
Q2 2022 Aug 15, 2022	BUY	$141.59 - $168.66 $373,089 - $444,419	2,635 Added 0.63%	423,079 $66 Million
Q1 2022 May 16, 2022	SELL	$129.64 - $160.7 $3.32 Million - $4.11 Million	-25,590 Reduced 5.74%	420,444 $67.2 Million
Q4 2021 Feb 14, 2022	SELL	$119.87 - $145.67 $452,269 - $549,612	-3,773 Reduced 0.84%	446,034 $56.8 Million
Q3 2021 Nov 12, 2021	SELL	$128.64 - $184.79 $44.4 Million - $63.8 Million	-345,349 Reduced 43.43%	449,807 $58.6 Million
Q2 2021 Aug 16, 2021	BUY	$160.2 - $186.42 $7.02 Million - $8.17 Million	43,806 Added 5.83%	795,156 $141 Million
Q1 2021 May 17, 2021	SELL	$150.19 - $173.5 $22.5 Million - $26 Million	-149,683 Reduced 16.61%	751,350 $123 Million
Q4 2020 May 17, 2021	BUY	$140.71 - $165.05 $5.93 Million - $6.95 Million	42,115 Added 4.9%	901,033 $149 Million
Q4 2020 Feb 16, 2021	SELL	$140.71 - $165.05 $80.5 Million - $94.4 Million	-572,063 Reduced 39.98%	858,918 $142 Million
Q3 2020 Nov 16, 2020	SELL	$105.46 - $144.13 $6.22 Million - $8.5 Million	-59,005 Reduced 3.96%	1,430,981 $204 Million
Q2 2020 Aug 14, 2020	SELL	$95.68 - $121.88 $14 Million - $17.8 Million	-145,857 Reduced 8.92%	1,489,986 $164 Million
Q1 2020 May 14, 2020	SELL	$87.74 - $152.74 $10.7 Million - $18.5 Million	-121,445 Reduced 6.91%	1,635,843 $163 Million
Q4 2019 Feb 14, 2020	SELL	$117.65 - $153.73 $21.7 Million - $28.4 Million	-184,667 Reduced 9.51%	1,757,288 $262 Million
Q3 2019 Nov 14, 2019	BUY	$125.18 - $143.24 $2.21 Million - $2.53 Million	17,685 Added 0.92%	1,941,955 $249 Million
Q2 2019 Aug 15, 2019	BUY	$125.55 - $144.48 $237 Million - $273 Million	1,886,384 Added 4979.11%	1,924,270 $274 Million
Q1 2019 May 14, 2019	BUY	$121.81 - $142.95 $3.28 Million - $3.85 Million	26,941 Added 246.15%	37,886 $5.42 Million
Q4 2018 Feb 14, 2019	BUY	$115.94 - $166.74 $62,955 - $90,539	543 Added 5.22%	10,945 $1.36 Million
Q3 2018 Nov 13, 2018	BUY	$161.01 - $180.57 $142,493 - $159,804	885 Added 9.3%	10,402 $1.75 Million
Q2 2018 Aug 14, 2018	BUY	$146.33 - $183.18 $227,835 - $285,211	1,557 Added 19.56%	9,517 $1.64 Million
Q3 2017 Nov 14, 2017	BUY	$142.62 - $155.6 $1.14 Million - $1.24 Million	7,960	7,960 $1.16 Million

Others Institutions Holding JAZZ

# of Institutions

490

Shares Held

57M

Call Options Held

155K

Put Options Held

152K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $6.95B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Jazz Pharmaceuticals PLC Transaction History